Mark has been a part of the investment team since the founding of OS Fund. In his time at OS Fund he has focused on diligence and sourcing of deals across Genomics, Synthetic Biology, and Advanced Materials. Mark has served as Board Advisor to multiple companies including Health Data Link (acquired by Datavant, 2019). He has previously worked directing investments at a single family office and as a portfolio manager. Mark graduated from Indiana University, and is a CFA charterholder.
Return to Team